- R1 RCM Inc. provides services to increase medical provider reimbursements and is an industry that grows at 10.3% annually.
- Changing regulations and the need to scale medical care across America will position R1 RCM Inc. to attract larger healthcare providers to its products and services.
- With a revenue growth rate of around 15% and an EBITDA margin of around 25 to 30%, the stock is currently undervalued.
- If strong financial performance on May 9th earnings is observed, the stock could rally 10% in the short run and up to 62.5% in the medium to long run.
For further details see:
R1 RCM: Undervalued Stock With 62.5% Upside